Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Vunakizumab in Plaque Psoriasis
NCT04839016Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Apr 2021
- Primary completion
- Aug 2023
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of vunakizumab in plaque psoriasis, sponsored by Hengrui. Status: unknown.
02
Drugs
vunakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04839016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839016.